Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Seattle Genetics CEO Clay Siegall: An Interview With “The Pink Sheet” DAILY (Part 1 Of 2)

This article was originally published in The Pink Sheet Daily

Executive Summary

Biotech chief exec sits down to talk about the comprehensive development program for SGN-40 in cancer and partnering with Genentech.
Advertisement

Related Content

Seattle Genetics CEO Clay Siegall: An Interview With “The Pink Sheet” DAILY (Part 2 Of 2)
Seattle Genetics CEO Clay Siegall: An Interview With “The Pink Sheet” DAILY (Part 2 Of 2)
Genentech Gets Non-Hodgkin’s Lymphoma Candidate With Seattle Genetics Deal
Genentech Gets Non-Hodgkin’s Lymphoma Candidate With Seattle Genetics Deal

Topics

Advertisement
UsernamePublicRestriction

Register